These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7499276)

  • 1. Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancer.
    Zhan S; Shapiro D; Zhan S; Zhang L; Hirschfeld S; Elassal J; Helman LJ
    J Biol Chem; 1995 Nov; 270(47):27983-6. PubMed ID: 7499276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
    Vu TH; Hoffman AR
    Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH; Hoffman A
    J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
    Taniguchi T; Schofield AE; Scarlett JL; Morison IM; Sullivan MJ; Reeve AE
    Oncogene; 1995 Aug; 11(4):751-6. PubMed ID: 7651739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
    Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
    J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parental imprinting of rat insulin-like growth factor II gene promoters is coordinately regulated.
    Pedone PV; Cosma MP; Ungaro P; Colantuoni V; Bruni CB; Zarrilli R; Riccio A
    J Biol Chem; 1994 Sep; 269(39):23970-5. PubMed ID: 7929045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter-specific IGF2 imprinting status and its plasticity during human liver development.
    Ekström TJ; Cui H; Li X; Ohlsson R
    Development; 1995 Feb; 121(2):309-16. PubMed ID: 7768174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cells.
    Zhang L; Zhan Q; Zhan S; Kashanchi F; Fornace AJ; Seth P; Helman LJ
    DNA Cell Biol; 1998 Feb; 17(2):125-31. PubMed ID: 9502429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
    Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
    Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
    Yballe CM; Vu TH; Hoffman AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH; Duan JX; Vu TH; Hoffman AR
    J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biallelic expression of all four IGF-II promoters and its association with increased methylation of H19 gene in human brain.
    Zhan S; Zhang L; Van M; Young C; Helman LJ
    Brain Res; 1998 May; 792(2):283-90. PubMed ID: 9593943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human insulin-like growth factor-II promoter P1 is not restricted to liver: evidence for expression of P1 in other tissues and for a homologous promoter in baboon liver.
    Jin IH; Sinha G; Yballe C; Vu TH; Hoffman AR
    Horm Metab Res; 1995 Oct; 27(10):447-9. PubMed ID: 8575722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors.
    Pedone PV; Tirabosco R; Cavazzana AO; Ungaro P; Basso G; Luksch R; Carli M; Bruni CB; Frunzio R; Riccio A
    Hum Mol Genet; 1994 Jul; 3(7):1117-21. PubMed ID: 7981680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin-like growth factor 2 imprinting status and promoter usage in the placenta of macrosomia].
    Yao JC; Hu YL; Wang ZQ; Dai YM; Ling JX; Ye XD
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):309-14. PubMed ID: 17673042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
    Wu HK; Squire JA; Song Q; Weksberg R
    Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon.
    Mineo R; Fichera E; Liang SJ; Fujita-Yamaguchi Y
    Biochem Biophys Res Commun; 2000 Feb; 268(3):886-92. PubMed ID: 10679300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata.
    Vu TH; Yballe C; Boonyanit S; Hoffman AR
    J Clin Endocrinol Metab; 1995 May; 80(5):1670-6. PubMed ID: 7745016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.